Canadian medical technology technology firm Theralase Technologies Inc (CVE:TLT, OTCMKTS:TLTFF) has qualified to trade on the OTCQX Best Market in the United States.
"Trading on the OTCQX will allow Theralase to build visibility and provide a more transparent market for U.S. investors," said Jason Paltrowitz, executive vice president of Corporate Services at OTC Markets Group.
Roger Dumoulin-White, president and chief executive officer of Theralase, expressed his delight at having qualified for trading on OTCQX by meeting high financial standards, following best practice corporate governance guidelines, demonstrating compliance with US securities laws and having a professional third-party sponsor introduction.
“All of these key characteristics of our company will provide security and transparency for US-based investors that elect to trade in our stock," he said